• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy.

作者信息

Singh Katelyn, Wang Alice, Heald Peter, McNiff Jennifer M, Suozzi Kathleen, King Brett, Leventhal Jonathan, Damsky William

机构信息

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

出版信息

JAAD Case Rep. 2020 Dec 1;7:122-124. doi: 10.1016/j.jdcr.2020.11.016. eCollection 2021 Jan.

DOI:10.1016/j.jdcr.2020.11.016
PMID:33426249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7777455/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ade/7777455/03489f89e284/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ade/7777455/03489f89e284/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ade/7777455/03489f89e284/gr1.jpg

相似文献

1
Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy.用2%托法替布软膏和脉冲染料激光疗法治疗血管性狼疮样结节病。
JAAD Case Rep. 2020 Dec 1;7:122-124. doi: 10.1016/j.jdcr.2020.11.016. eCollection 2021 Jan.
2
Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment.使用阿达木单抗和2%托法替布软膏治疗难治性血管狼疮样结节病
JAAD Case Rep. 2023 Jun 15;38:61-63. doi: 10.1016/j.jdcr.2023.06.006. eCollection 2023 Aug.
3
Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.Janus 激酶抑制可诱导皮肤结节病和环状肉芽肿缓解。
J Am Acad Dermatol. 2020 Mar;82(3):612-621. doi: 10.1016/j.jaad.2019.05.098. Epub 2019 Jun 8.
4
Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil.用2%托法替布软膏和特级初榨橄榄油治疗皮肤结节病。
JAAD Case Rep. 2020 Dec 25;9:1-3. doi: 10.1016/j.jdcr.2020.12.021. eCollection 2021 Mar.
5
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis.托法替布治疗皮肤结节病：一例病例报告及结节病中 Janus 激酶抑制作用的证据综述
JAAD Case Rep. 2021 Aug 20;16:62-64. doi: 10.1016/j.jdcr.2021.08.012. eCollection 2021 Oct.
6
Treatment of Multiorgan Sarcoidosis With Tofacitinib.托法替布治疗多器官结节病
ACR Open Rheumatol. 2020 Feb;2(2):106-109. doi: 10.1002/acr2.11112. Epub 2020 Jan 9.
7
JAK-inhibitor Tofacitinib in Severe Laryngeal Sarcoidosis: A Case Report.JAK抑制剂托法替布治疗重度喉结节病：一例报告
Laryngoscope. 2025 Feb;135(2):829-832. doi: 10.1002/lary.31778. Epub 2024 Sep 19.
8
Treatment of granuloma annulare with tofacitinib 2% ointment.用2%托法替布软膏治疗环状肉芽肿。
JAAD Case Rep. 2019 Dec 30;6(1):69-71. doi: 10.1016/j.jdcr.2019.10.016. eCollection 2020 Jan.
9
Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis.托法替尼治疗与皮肤结节病的分子分析。
N Engl J Med. 2018 Dec 27;379(26):2540-2546. doi: 10.1056/NEJMoa1805958.
10
Combined pulsed-dye laser and medical therapy for treatment of cutaneous sarcoidosis lesions: a case report.联合脉冲染料激光与药物治疗皮肤结节病皮损：一例报告
J Int Med Res. 2021 Mar;49(3):300060521997745. doi: 10.1177/0300060521997745.

引用本文的文献

1
Recent Clinical Studies on the Effects of Tumor Necrosis Factor-Alpha (TNF-α) and Janus Kinase/Signal Transducers and Activators of Transcription (JAK/STAT) Antibody Therapies in Refractory Cutaneous Sarcoidosis: A Systematic Review.肿瘤坏死因子-α（TNF-α）和Janus激酶/信号转导子与转录激活子（JAK/STAT）抗体疗法对难治性皮肤结节病影响的近期临床研究：一项系统评价
Cureus. 2023 Sep 8;15(9):e44901. doi: 10.7759/cureus.44901. eCollection 2023 Sep.
2
Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A Review of the Evidence and Implications for Understanding Disease Pathogenesis.炎症性皮肤肉芽肿性疾病的分子靶向治疗：证据综述及对理解疾病发病机制的启示
JID Innov. 2023 Aug 10;3(5):100220. doi: 10.1016/j.xjidi.2023.100220. eCollection 2023 Sep.
3

本文引用的文献

1
Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.Janus 激酶抑制可诱导皮肤结节病和环状肉芽肿缓解。
J Am Acad Dermatol. 2020 Mar;82(3):612-621. doi: 10.1016/j.jaad.2019.05.098. Epub 2019 Jun 8.
2
Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera.用于伴发真性红细胞增多症的Janus激酶抑制剂治疗后皮肤结节病的消退
JAAD Case Rep. 2019 Apr 5;5(4):360-361. doi: 10.1016/j.jdcr.2019.02.006. eCollection 2019 Apr.
3
Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis.
Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment.使用阿达木单抗和2%托法替布软膏治疗难治性血管狼疮样结节病
JAAD Case Rep. 2023 Jun 15;38:61-63. doi: 10.1016/j.jdcr.2023.06.006. eCollection 2023 Aug.
4
Ruxolitinib cream for the treatment of cutaneous sarcoidosis.用于治疗皮肤结节病的芦可替尼乳膏。
JAAD Case Rep. 2023 Jun 3;38:111-112. doi: 10.1016/j.jdcr.2023.05.032. eCollection 2023 Aug.
5
Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome.托法替尼，一种 NOD2 表达的抑制剂，是一种治疗 Blau 综合征的潜在药物。
Front Immunol. 2023 Jun 21;14:1211240. doi: 10.3389/fimmu.2023.1211240. eCollection 2023.
6
Cutaneous sarcoidosis mimicking pigmented purpuric dermatosis.皮肤结节病样色素性紫癜性皮炎。
J Cutan Pathol. 2023 Feb;50(2):123-126. doi: 10.1111/cup.14326. Epub 2022 Sep 21.
7
The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.皮肤结节病的演变格局：发病机制的新见解、临床面临的挑战和治疗的新领域。
Am J Clin Dermatol. 2022 Jul;23(4):499-514. doi: 10.1007/s40257-022-00693-0. Epub 2022 May 18.
8
The CSF in neurosarcoidosis contains consistent clonal expansion of CD8 T cells, but not CD4 T cells.神经结节病患者的脑脊液中存在一致的 CD8 T 细胞克隆性扩增，但不存在 CD4 T 细胞。
J Neuroimmunol. 2022 Jun 15;367:577860. doi: 10.1016/j.jneuroim.2022.577860. Epub 2022 Apr 1.
9
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis.托法替布治疗皮肤结节病：一例病例报告及结节病中 Janus 激酶抑制作用的证据综述
JAAD Case Rep. 2021 Aug 20;16:62-64. doi: 10.1016/j.jdcr.2021.08.012. eCollection 2021 Oct.
托法替尼治疗与皮肤结节病的分子分析。
N Engl J Med. 2018 Dec 27;379(26):2540-2546. doi: 10.1056/NEJMoa1805958.
4
Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia.鲁索替尼治疗难治性结节病伴JAK2突变型真性红细胞增多症患者的显著疗效
Eur Respir J. 2018 Dec 20;52(6). doi: 10.1183/13993003.01482-2018. Print 2018 Dec.
5
Cutaneous sarcoidosis.皮肤结节病
Curr Opin Pulm Med. 2017 Sep;23(5):482-486. doi: 10.1097/MCP.0000000000000402.
6
T-cell immunology in sarcoidosis: Disruption of a delicate balance between helper and regulatory T-cells.结节病中的T细胞免疫学：辅助性T细胞与调节性T细胞之间微妙平衡的破坏。
Curr Opin Pulm Med. 2016 Sep;22(5):476-83. doi: 10.1097/MCP.0000000000000303.
7
A practical approach to cutaneous sarcoidosis.皮肤结节病的实用方法。
Am J Clin Dermatol. 2014 Aug;15(4):283-97. doi: 10.1007/s40257-014-0079-3.
8
Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.评估皮肤结节病的皮肤结节病活动和形态学工具的可靠性和收敛有效性。
JAMA Dermatol. 2013 May;149(5):550-6. doi: 10.1001/jamadermatol.2013.60.
9
Cutaneous sarcoidosis in southern Taiwan: clinicopathologic study of a series with high proportions of lesions confined to the face and angiolupoid variant.台湾南部的皮肤结节病：一系列以局限于面部和血管样变型病变比例高为特征的临床病理研究。
J Eur Acad Dermatol Venereol. 2013 Apr;27(4):499-505. doi: 10.1111/j.1468-3083.2012.04473.x. Epub 2012 Feb 20.
10
The successful treatment of lupus pernio with the flashlamp pulsed dye laser.
J Cutan Laser Ther. 1999 Jan;1(1):49-52. doi: 10.1080/14628839950517101.